M&A Deal Summary

Quest Diagnostics Acquires AmeriPath

On April 16, 2007, Quest Diagnostics acquired healthcare services company AmeriPath from Welsh Carson Anderson & Stowe and Summit Partners for 2.0B USD

Acquisition Highlights
  • This is Quest Diagnostics’ 5th transaction in the Healthcare Services sector.
  • This is Quest Diagnostics’ largest (disclosed) transaction.
  • This is Quest Diagnostics’ 5th transaction in the United States.
  • This is Quest Diagnostics’ 1st transaction in Florida.

M&A Deal Summary

Date 2007-04-16
Target AmeriPath
Sector Healthcare Services
Buyer(s) Quest Diagnostics
Sellers(s) Welsh Carson Anderson & Stowe
Summit Partners
Deal Type Add-on Acquisition
Deal Value 2.0B USD
Advisor(s) Ropes & Gray (Legal)

Target

AmeriPath

Orlando, Florida, United States
website
AmeriPath, Inc. is a leading national provider of anatomic pathology, dermatopathology and molecular diagnostic services to physicians, hospitals, clinical laboratories and surgery centers across the U.S.

Search 192,510 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Quest Diagnostics

Secaucus, New Jersey, United States

website


Category Company
Founded 1967
Sector Healthcare Services
Employees40,000
Revenue 9.9B USD (2022)
DESCRIPTION

Quest Diagnostics is the world's leading provider of diagnostic information services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic information services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics was founded in 1967 and is based in Secaucus, New Jersey.


DEAL STATS #
Overall 6 of 37
Sector (Healthcare Services) 5 of 22
Type (Add-on Acquisition) 6 of 25
State (Florida) 1 of 1
Country (United States) 5 of 35
Year (2007) 2 of 2
Size (of disclosed) 1 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-02-01 HemoCue AB

Angelholm, Sweden

For more than 10 years, HemoCue had been a recognized global leader in professional diagnostics point-of-care testing. The product strategies behind HemoCue's success where based on a clear focus on important diagnostic tests of the highest quality, which was fast and easy to perform by anyone.

Buy $420M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-12-09 Pathway Diagnostics

Malibu, California, United States

Pathway Diagnostics Corp. is a full-service biomarker assay development and commercialization company that uniquely combines expertise in clinical biomarker diagnostics with access to intellectual property, a broad range of technology platforms, and full-service central laboratory for clinical trials that is licensed under CLIA/CAP and compliant with GLP/GCP regulations.

Buy -

Seller(S) 2

SELLER

Welsh Carson Anderson & Stowe

New York, New York, United States

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 1979
PE ASSETS 27.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Welsh Carson Anderson & Stowe (WCAS) is a mega-sized, specialist private equity firm focused on investments in growth-oriented companies operating within the healthcare and technology/tech-enabled services industries. WCAS will consider small and large transactions; including venture investments, growth equity investments, buy-and-build transactions, public-to-private acquisitions, and corporate carve-outs. The Firm prefers control situations and generally seeks opportunities in the US. Welsh Carson Anderson & Stowe was formed in 1979 and is based in New York City.


DEAL STATS #
Overall 15 of 73
Sector (Healthcare Services) 8 of 25
Type (Add-on Acquisition) 8 of 43
State (Florida) 2 of 3
Country (United States) 14 of 70
Year (2007) 1 of 5
Size (of disclosed) 5 of 33
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-01-08 United Surgical Partners International

Addison, Texas, United States

United Surgical Partners International, Inc. is a develops ambulatory surgery centers primarily in partnership with hospitals and with physicians in the U.S.

Buy $1.8B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-05-03 The BISYS Group

New York, New York, United States

The BISYS Group, Inc. provides outsourcing solutions that help investment firms and insurance companies to more efficiently serve their customers, grow their businesses, and respond to evolving regulatory requirements.

Sell $1.5B
SELLER

Summit Partners

Boston, Massachusetts, United States

Investor Investor Investor Investor Investor

website


Category Growth Capital Firm
Founded 1984
PE ASSETS 39.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Summit Partners is a private investment and asset management firm focused on venture, growth, credit, and public equity investing. Sectors of interest include business services, communications technology and services, consumer products, energy, financial services, healthcare and life sciences, industrial products, internet/information services, media/entertainment, semiconductors, electronics, and software. Summit Partners is known for having a proactive business development group for sourcing transactions. Summit will consider both minority or majority investment stakes and is willing to commit as little as $10 million or as much as $500 million in combined debt/junior capital per transaction. The Firm's geographic coverage spans North America and Europe. Summit Partners was formed in 1984 and is headquartered in Boston, Massachusetts.


DEAL STATS #
Overall 129 of 281
Sector (Healthcare Services) 10 of 32
Type (Add-on Acquisition) 56 of 126
State (Florida) 8 of 17
Country (United States) 125 of 243
Year (2007) 3 of 12
Size (of disclosed) 4 of 49
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-02-28 Hyperion Solutions

Santa Clara, California, United States

Hyperion Software creates applications that support enterprise wide financial planning budgeting, forecasting, consolidation and business analysis.

Sell $3.3B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-04-19 National Veterinary Associates

Agoura Hills, California, United States

National Veterinary Associates, Inc. is one of the largest veterinary and pet care services organizations in the world. NVA partners with over 700 general practice hospitals, specialty + ER hospitals, equine hospitals, and pet resorts in the U.S., Canada, Australia, and New Zealand. NVA’s 14,000 team members and 2,600 veterinarians are united by a common purpose – a love for animals and the people who love them – and a common mission – to improve the comfort and well-being of animals by providing progressive and compassionate care. NVA’s veterinarians and animal care professionals provide a full range of medical and surgical services. T

Buy -